AARD Aardvark Pharma: Rasio rega marang prakiraan pendapatan

Aardvark Therapeutics Inc - logo grafis emiten AARD

Aardvark Therapeutics Inc (AARD) is developing oral anti-obesity treatments that target intestinal receptors to suppress appetite. The forward P/S history confirms market expectations, with the metric currently at . The startup focuses on TAS2R receptors for safe weight loss, however, high R&D costs in the absence of sales are leading to a gradual depletion of existing cash reserves.

Aardvark Therapeutics - Rasio kapitalisasi marang dodolan sing dikarepake AARD (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis Aardvark Therapeutics Inc (AARD)

Analisis fundamental perusahaan:Aardvark Therapeutics Inc. AARD
Produk asli Aardvark Pharma

Since Aardvark Therapeutics Inc (AARD) is in the clinical research stage without commercial revenue, operational scalability of the business remains unattainable. This indicator calculates the ratio of current market capitalization to projected sales, allowing the market to value future cash flows; meanwhile, the forward price-to-sales valuation trend serves as a signal regarding the extent of the premium paid for the potential of the company's R&D assets.

Pesaing Aardvark Therapeutics Inc

Rasio rega marang prakiraan pendapatan ascendispharma.com ASND|Madrigal Corp (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MoonLake Corp|Crinetics Corp (CRNX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan newamsterdampharma.com (NAMS)|Multiplikator forward rega marang pendapatan soleno.life SLNO|Multiplikator Forward P/S FOLD (amicusrx.com)|Rasio kapitalisasi marang dodolan sing dikarepake 89bio (ETNB)|Agios - Multiplikator Forward P/S|Structure Corp - Rasio rega marang pendapatan sing dikarepake|mimedx.com (MDXG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan MBX|Rasio rega marang prakiraan pendapatan Altimmune Pharma (ALT)|Multiplikator forward rega marang pendapatan Sagimet SGMT|Multiplikator Forward P/S BIOA (BioAge Labs)|Multiplikator Forward P/S Biomea Fusion BMEA|QNCX: Multiplikator forward rega marang pendapatan|GUTS: Rasio rega marang prakiraan pendapatan|vTv Therapeutics Inc (VTVT) - Rasio rega marang prakiraan pendapatan|ATPC: Rasio rega marang pendapatan sing dikarepake|PLUR (pluri-biotech.com) - Multiplikator Forward P/S|SYBX: Rega forward marang dodolan|Multiplikator Forward P/S LPCN|Rasio kapitalisasi marang dodolan sing dikarepake Matinas BioPharma Holdings, Inc.|Rasio rega marang prakiraan pendapatan Spruce Biosciences Inc. SPRB|GLTO - Multiplikator forward rega marang pendapatan|CTCX - Rasio rega marang prakiraan pendapatan|LUMO - Multiplikator Forward P/S|ONVO: Multiplikator Forward P/S|RDUS (Radius Recycling) - Rasio rega marang prakiraan pendapatan